Mexican radiationdermatitis management consensus

Area of Science:

• Oncology
• Dermatology
• Radiation Oncology

Background:

• Radiotherapy (RT) is a cornerstone of cancer treatment, with 50-70% of patients receiving it.
• Radiation dermatitis (RD) affects approximately 95% of patients undergoing RT, significantly impacting their quality of life.
• A lack of standardized consensus and limited clinical trials highlight the need for evidence-based RD management guidelines.

Purpose of the Study:

• To develop a clinical guide for the prevention and management of radiation dermatitis (RD).
• To establish a consensus among Mexican radiation oncologists based on national practice and international evidence.

Main Methods:

• A panel of 25 Mexican radiation oncologists participated.
• Criteria were gathered using the Delphi Method and a review of relevant literature.
• 21 questions regarding RD treatment experience were voted on by the panel.

Main Results:

• Over 80% agreement was reached on using dermocosmetics/medical devices for preventing and treating RD grades 1-2.
• For grade 3 RD, individualized case management and dermatologist evaluation are recommended.
• Topical steroids are advised for skin itching or pain; natural soaking elements and continued skin care are suggested to mitigate late radiation skin lesions.

Conclusions:

• The developed consensus serves as an educational tool for healthcare professionals treating RT patients.
• The guide is adaptable to individual clinical needs, supporting optimal RD management.
• Emphasis is placed on proactive skin care to prevent and manage both acute and late radiation skin effects.